Question 1

Is Dihydroergotamine considered a triptan?

Accepted Answer

No, Dihydroergotamine is not a triptan; it belongs to the class of medications known as ergots. While it operates similarly to triptans like sumatriptan (Imitrex) or rizatriptan (Maxalt), which are also used to treat migraines and cluster headaches, they differ in their chemical classification. Both ergots and triptans can cause similar side effects. It’s important to avoid taking Dihydroergotamine and triptan medications within 24 hours of each other to prevent the risk of dangerously high blood pressure and other severe side effects.

Question 2

Can Dihydroergotamine cause rebound headaches?

Accepted Answer

Dihydroergotamine, when used as directed, typically does not cause rebound headaches, which are also known as medication-overuse headaches. This medication is effective in stopping headaches, and its effects tend to last longer than those of many other treatments, reducing the likelihood of experiencing another headache shortly thereafter. It is crucial to use this medication strictly according to your healthcare provider’s instructions. If you find that Dihydroergotamine is not effective, or if you find yourself using it more frequently than recommended, consult your healthcare provider for guidance.

Question 3

What should I avoid while using Dihydroergotamine injections?

Accepted Answer

Avoid using Dihydroergotamine within 24 hours before or after taking other migraine medications. This includes other ergot medicines (such as ergotamine and methylergonovine) and triptan medications (such as almotriptan and eletriptan), as combining these can lead to serious side effects. Additionally, grapefruit and grapefruit products may interact with dihydroergotamine, potentially causing adverse effects. It is best to avoid grapefruit products while using this medication.

Question 4

Can Dihydroergotamine cause drowsiness?

Accepted Answer

Dihydroergotamine is not commonly associated with causing drowsiness. In clinical studies, only about 3% of people who used the nasal spray form of this medication reported feeling drowsy. Additionally, while rare, some users may experience fatigue or a general sense of weakness. These side effects are generally uncommon.

Dihydroergotamine Mesylate Injection USP